Our group showed PANX1 levels are increased in melanoma cells compared to normal melanocytes, and PANX1 mRNA is upregulated in patient melanoma tumour samples compared to control skin, with levels remaining high throughout all stages of melanoma disease progression (Freeman et al., 2019; Penuela et al., 2012). This evidence concerns the gene PANX1 and neoplasm.